Acambis Says Willing To Settle In Patent Fight
Last week, an International Trade Commission administrative law judge ruled that Bavarian Nordic's patents for a smallpox vaccine are invalid, giving rival Acambis a leg up in a fight over millions of dollars in U.S. anti-terror funding.
"We have been open to settlement discussions from the beginning and were happy to...
Already a subscriber? Click here to login